About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

MIZUHO MEDY CO.,LTD.(4595) Summary

4595
TSE Standard
MIZUHO MEDY CO.,LTD.
1,507
JPY
+2
(+0.13%)
May 1, 3:30 pm JST
10.45
USD
May 1, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
8.8
PBR
1.65
Yield
5.64%
Margin Trading Ratio
Stock Price
May 1, 2025
Opening May 1, 9:00 am
1,514 JPY 10.58 USD
Previous Close Apr 30
1,505 JPY 10.55 USD
High May 1, 9:00 am
1,514 JPY 10.58 USD
Low May 1, 1:57 pm
1,498 JPY 10.41 USD
Volume
38,800
Trading Value
0.06B JPY 0.40M USD
VWAP
1504.02 JPY 10.43 USD
Minimum Trading Value
150,700 JPY 1,045 USD
Market Cap
0.03T JPY 0.20B USD
Number of Trades
138
Liquidity & Number of Trades
As of May 1, 2025
Liquidity
Mid
1-Year Average
282
1-Year High Jan 27, 2025
1,966
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 25, 2025 0 250,800
Apr 18, 2025 0 245,600
Apr 11, 2025 0 263,700
Apr 4, 2025 0 303,800
Mar 28, 2025 0 323,600
Company Profile
MIZUHO MEDY CO.,LTD. develops, manufactures, and sells in vitro diagnostic medical devices. The company's main products include virus detection kits and pregnancy tests.
Sector
Pharmaceuticals
MIZUHO MEDY CO.,LTD. specializes in in vitro diagnostic medical devices for healthcare, with a focus on influenza test kits. The company conducts proprietary research and development with the aim of obtaining patents, as well as collaborative research with industry, academia, and government. Based on ISO13485 quality management standards, MIZUHO MEDY has established an integrated in-house system for development, manufacturing, and sales, providing high-quality products that meet the needs of medical professionals. Their main products are immunoserological test reagents, primarily rapid and simple test kits using immunochromatography for detecting infectious diseases such as influenza and adenovirus. In recent years, the company has also developed genetic POCT testing systems, offering test kits for mycoplasma and the novel coronavirus. In the OTC market, MIZUHO MEDY offers pregnancy tests and ovulation predictor kits.